symptoms

Strattera Withdrawal Symptoms: Eye Effects and Other Signs to Watch For

Medically reviewed by Dr. Sarah Mitchell, MD, FASAM · Updated March 17, 2026
Strattera Withdrawal Symptoms: Eye Effects and Other Signs to Watch For

Why Strattera Causes Withdrawal Symptoms

Strattera (atomoxetine) is a selective norepinephrine reuptake inhibitor (SNRI) used for ADHD. Unlike stimulant ADHD medications, Strattera builds up in the body over weeks and alters norepinephrine signaling across multiple organ systems. When discontinued, the body must readjust to functioning without augmented norepinephrine activity. This readjustment produces withdrawal symptoms.

Strattera is not considered addictive, and withdrawal is not dangerous. But the symptoms are real, uncomfortable, and can last 2 to 6 weeks.

Atomoxetine affects the autonomic nervous system, which controls pupil size, tear production, and focusing. Withdrawal disrupts this regulation:

Blurred Vision

The most commonly reported eye symptom during Strattera withdrawal. Atomoxetine’s anticholinergic properties affect the ciliary muscle (which controls lens focusing). When the drug is removed, the muscle readjusts over 1 to 3 weeks. Objects at close range may appear out of focus.

Dry Eyes

Norepinephrine influences tear production through the lacrimal gland. Withdrawal can temporarily alter tear output, producing dry, irritated eyes. Artificial tears (preservative-free) provide relief.

Pupil Size Changes

Atomoxetine can cause mild pupil dilation (mydriasis) during use through its noradrenergic effects. During withdrawal, pupils may fluctuate in size as the autonomic nervous system recalibrates. Some people report increased light sensitivity during this period.

Eye Strain and Headache

The combination of blurred vision and concentration difficulty during withdrawal produces eye strain. This often presents as a dull headache behind or around the eyes, especially after reading or screen work.

A 2020 pharmacovigilance study analyzing FDA adverse event reports for atomoxetine found that visual disturbances were reported in 4.2% of discontinuation cases. Blurred vision was the most common visual complaint, followed by dry eyes. All cases resolved within 6 weeks of discontinuation.

Non-Eye Withdrawal Symptoms

Most Common

  • Fatigue: Deep exhaustion in the first 1 to 2 weeks. Often the first and most disruptive symptom.
  • ADHD symptom rebound: Attention, focus, organization, and impulse control decline. Tasks managed on medication become difficult.
  • Irritability: Frustration tolerance drops. Emotional reactions feel disproportionate.
  • Mood changes: Low mood, anxiety, emotional flatness, or mood swings.

Moderately Common

  • Insomnia or hypersomnia: Sleep pattern disruption in either direction.
  • Vivid dreams: Unusually intense or disturbing dreams, especially in the first 2 weeks.
  • Headaches: Tension-type headaches lasting 3 to 7 days.
  • Nausea: GI discomfort, usually mild and resolving within a week.
  • Appetite changes: Appetite typically increases since Strattera suppresses it during use.

Less Common

  • Dizziness: Lightheadedness, especially when standing quickly.
  • Brain zaps: Brief electrical-shock sensations in the head. Similar to SSRI discontinuation syndrome.
  • Muscle aches: Generalized body soreness without clear cause.

Withdrawal Timeline

  • Days 1 to 3: Fatigue, ADHD symptoms return, headache, possible nausea.
  • Days 4 to 10: Peak symptoms. Mood changes, sleep disruption, eye effects begin.
  • Weeks 2 to 3: Gradual improvement. Physical symptoms (nausea, headache) resolve first.
  • Weeks 3 to 6: Mood stabilizes. ADHD symptoms settle at pre-medication baseline. Eye effects resolve.

Tapering vs Stopping Abruptly

Gradual dose reduction (tapering) over 2 to 4 weeks reduces the severity and duration of withdrawal symptoms. A standard taper from 80 mg daily: 60 mg for one week, 40 mg for one week, 25 mg for one week, then stop. Your prescriber will adjust based on your response.

Never change your Strattera dose without consulting your prescriber. Abrupt discontinuation is not dangerous but produces more intense symptoms.

Managing Eye Symptoms

  1. Artificial tears: Use preservative-free drops 3 to 4 times daily for dry eyes.
  2. Reduce screen time: Follow the 20-20-20 rule (every 20 minutes, look at something 20 feet away for 20 seconds).
  3. Adjust lighting: Reduce brightness on screens. Use warm-toned light if experiencing light sensitivity.
  4. Wear reading glasses: If blurred near vision is significant, temporary reading glasses may help until the symptom resolves.

When to Contact Your Doctor

Contact your prescriber if withdrawal symptoms are severe enough to impair daily functioning, if you experience suicidal thoughts at any point (FDA black box warning applies), or if eye symptoms do not improve within 4 weeks. SAMHSA (1-800-662-4357) provides free, confidential behavioral health referrals.

Sources

This article was medically reviewed and draws from peer-reviewed research and clinical guidelines published by:

Content is reviewed for medical accuracy by our editorial team. Last reviewed: March 17, 2026.

Medical Disclaimer: This article is for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making changes to your treatment plan. If you are experiencing a medical emergency, call 911 immediately. For substance use support, call SAMHSA at 1-800-662-4357 (free, confidential, 24/7).

Need Help Now? Call 1-800-662-4357